Literature DB >> 10854272

The postsynaptic density protein PSD-95 differentially regulates insulin- and Src-mediated current modulation of mouse NMDA receptors expressed in Xenopus oocytes.

G Y Liao1, M A Kreitzer, B J Sweetman, J P Leonard.   

Abstract

The NMDA subtype of glutamate receptor is physically associated with the postsynaptic density protein PSD-95 at glutamatergic synapses. The channel activity of NMDA receptors is regulated by different signaling molecules, including protein tyrosine kinases. Because previous results have suggested a role for protein kinase C (PKC) in insulin potentiation of NMDA currents in oocytes, the effects of coexpression of PSD-95 on insulin and PKC potentiation of NMDA currents from these receptors were compared. Another primary objective was to determine if PSD-95 could enable Src to potentiate currents from NR2A/NR1 and NR2B/NR1 receptors expressed in Xenopus oocytes. The results show opposite effects of PSD-95 coexpression on Src and insulin modulation of NR2A/NR1 receptor currents. Src potentiation of mouse NR2A/NR1 currents required PSD-95 coexpression. In contrast, PSD-95 coexpression eliminated insulin-mediated potentiation of NR2A/NR1 receptor currents. PSD-95 coexpression also eliminated PKC potentiation of NR2A/NR1 receptor currents. PSD-95 may therefore play a key role in controlling kinase modulation of NR2A/NR1 receptor currents at glutamatergic synapses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854272     DOI: 10.1046/j.1471-4159.2000.0750282.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Synaptic plasticity and phosphorylation.

Authors:  Hey-Kyoung Lee
Journal:  Pharmacol Ther       Date:  2006-08-14       Impact factor: 12.310

2.  Two adaptor proteins differentially modulate the phosphorylation and biophysics of Kv1.3 ion channel by SRC kinase.

Authors:  Karen K Cook; Debra A Fadool
Journal:  J Biol Chem       Date:  2002-01-25       Impact factor: 5.157

3.  PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating.

Authors:  Ying Lin; Teresa Jover-Mengual; Judy Wong; Michael V L Bennett; R Suzanne Zukin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

4.  The upregulation of NR2A-containing N-methyl-D-aspartate receptor function by tyrosine phosphorylation of postsynaptic density 95 via facilitating Src/proline-rich tyrosine kinase 2 activation.

Authors:  Chao Zhao; Cai-Ping Du; Yan Peng; Zhen Xu; Chang-Cheng Sun; Yong Liu; Xiao-Yu Hou
Journal:  Mol Neurobiol       Date:  2014-07-01       Impact factor: 5.590

5.  Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation.

Authors:  H Guo; L Y Huang
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

6.  Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis.

Authors:  V A Skeberdis; J Lan; X Zheng; R S Zukin; M V Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 7.  The Regulation of GluN2A by Endogenous and Exogenous Regulators in the Central Nervous System.

Authors:  Yongjun Sun; Liying Zhan; Xiaokun Cheng; Linan Zhang; Jie Hu; Zibin Gao
Journal:  Cell Mol Neurobiol       Date:  2016-06-02       Impact factor: 5.046

8.  NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95.

Authors:  Lavan Sornarajah; Oana Cristina Vasuta; Lily Zhang; Christine Sutton; Bo Li; Alaa El-Husseini; Lynn A Raymond
Journal:  J Neurophysiol       Date:  2008-04-09       Impact factor: 2.714

Review 9.  Role of the brain-derived neurotrophic factor at glutamatergic synapses.

Authors:  A L Carvalho; M V Caldeira; S D Santos; C B Duarte
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

10.  Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells.

Authors:  Valerie J Collett; Graham L Collingridge
Journal:  Br J Pharmacol       Date:  2004-06-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.